UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Letter from Taiwan

Respirology (Carlton, Vic.), 2023-11, Vol.28 (11), p.1082-1083

2023

Volltextzugriff (PDF)

Considering lead-time bias in evaluating the effectiveness of lung cancer screening with real-world data

Scientific reports, 2021-06, Vol.11 (1), p.12180-12180, Article 12180

2021

Volltextzugriff (PDF)

Cost‐effectiveness of first‐line immunotherapies for advanced non‐small cell lung cancer

Cancer medicine (Malden, MA), 2023-04, Vol.12 (7), p.8838-8850

2023

Volltextzugriff (PDF)

PM2.5 exposure and risk of lung adenocarcinoma in women of Taiwan: A case–control study with density sampling

Respirology (Carlton, Vic.), 2022-11, Vol.27 (11), p.951-958

2022

Volltextzugriff (PDF)

Trend of Non-contrast Chest Computed Tomography Use in the Lung Cancer Screening Era: SEER-Medicare 2008–2016

Journal of general internal medicine : JGIM, 2021-11, Vol.36 (11), p.3589-3591

2021

Volltextzugriff (PDF)

The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasis

PloS one, 2018-02, Vol.13 (2), p.e0192161-e0192161

2018

Volltextzugriff (PDF)

Estimation of disability free life expectancy in non small cell lung cancer based on real world data

Scientific reports, 2023-08, Vol.13 (1), p.13318-13318, Article 13318

2023

Volltextzugriff (PDF)

The impact of driver mutation on the treatment outcome of early-stage lung cancer patients receiving neoadjuvant immunotherapy and chemotherapy

Scientific reports, 2022-02, Vol.12 (1), p.3319-3319, Article 3319

2022

Volltextzugriff (PDF)

Estimating Taiwan's QALY league table for catastrophic illnesses: Providing real-world evidence to integrate prevention with treatment for resources allocation

Journal of the Formosan Medical Association, 2024-11, Vol.123, p.S234-S241

2024

Volltextzugriff (PDF)

Liquid biopsy genotyping in lung cancer: ready for clinical utility?

Oncotarget, 2017-03, Vol.8 (11), p.18590-18608

2017

Volltextzugriff (PDF)

Economic Analysis of Tissue-First, Plasma-First, and Complementary NGS Approaches for Treatment-Naïve Metastatic Lung Adenocarcinoma

Frontiers in oncology, 2022-05, Vol.12, p.873111-873111

2022

Volltextzugriff (PDF)

Lung cancer survival and mortality in Taiwan following the initial launch of targeted therapies: an interrupted time series study

BMJ open, 2020-05, Vol.10 (5), p.e033427-e033427

2020

Volltextzugriff (PDF)

Effects of removing reimbursement restrictions on targeted therapy accessibility for non-small cell lung cancer treatment in Taiwan: an interrupted time series study

BMJ open, 2019-03, Vol.9 (3), p.e022293-e022293

2019

Volltextzugriff (PDF)

Preventing and treating brain metastases with three first-line EGFR-tyrosine kinase inhibitors in patients with EGFR mutation-positive advanced non-small cell lung cancer

Therapeutic advances in medical oncology, 2018-01, Vol.10, p.1758835918797589-1758835918797589

2018

Volltextzugriff (PDF)

Cost-Effectiveness of Nivolumab Plus Ipilimumab With and Without Chemotherapy for Advanced Non-Small Cell Lung Cancer

Frontiers in oncology, 2021-12, Vol.11, p.760686-760686

2021

Volltextzugriff (PDF)

Effect of BIM expression on the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs

Scientific reports, 2023-03, Vol.13 (1), p.3943-3943, Article 3943

2023

Volltextzugriff (PDF)

QALYs and medical costs saved from prevention of a cancer: Analysis of nation-wide real-world data of Taiwan with lifetime horizon

Journal of the Formosan Medical Association, 2021-12, Vol.120 (12), p.2089-2099

2021

Volltextzugriff (PDF)

Typical antipsychotics is associated with increased risk of severe exacerbation in asthma patients: a nationwide population-based cohort study

BMC pulmonary medicine, 2022-03, Vol.22 (1), p.85-85, Article 85

2022

Volltextzugriff (PDF)

Downstream Complications and Healthcare Expenditure after Invasive Procedures for Lung Lesions in Taiwan

International journal of environmental research and public health, 2021-04, Vol.18 (8), p.4040

2021

Volltextzugriff (PDF)

Estimating time and transportation costs associated with lung cancer screening and diagnostic lung procedures in Taiwan: a cross-sectional survey in a medical centre

BMJ open, 2023-03, Vol.13 (3), p.e070647-e070647

2023

Volltextzugriff (PDF)

Pembrolizumab and Chemotherapy Combination Prolonged Progression-Free Survival in Patients with NSCLC with High PD-L1 Expression and Low Neutrophil-to-Lymphocyte Ratio

Pharmaceuticals (Basel, Switzerland), 2022-11, Vol.15 (11), p.1407

2022

Volltextzugriff (PDF)

Indigenous recurrent disseminated histoplasmosis in Taiwan

Journal of microbiology, immunology and infection, 2020-12, Vol.53 (6), p.1047-1049

2020

Volltextzugriff (PDF)

EGFR-TKI plus bevacizumab versus EGFR-TKI monotherapy for patients with EGFR mutation-positive advanced non-small cell lung cancer-A propensity score matching analysis

Journal of the Formosan Medical Association, 2021-09, Vol.120 (9), p.1729-1739

2021

Volltextzugriff (PDF)

Multiple in-hospital counseling increases six-month smoking abstinence among individuals participating in a hospital-initiated smoking cessation program

Addiction science & clinical practice, 2022-05, Vol.17 (1), p.29-29, Article 29

2022

Volltextzugriff (PDF)

Improved survival in patients with unresectable stage III EGFR‐mutant adenocarcinoma with upfront EGFR‐tyrosine kinase inhibitors

Thoracic cancer, 2022-01, Vol.13 (2), p.182-189

2022

Volltextzugriff (PDF)

1 – 25 von 102

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(94)
Mit Volltextzugriff
(99)

Publikationsform

Sprache

Englisch
(100)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(79)
Life Sciences & Biomedicine
(58)
Humans
(51)
Female
(33)
Male
(28)
Aged
(25)
Middle Aged
(25)
Lung Cancer
(24)
Oncology
(18)
Science & Technology - Other Topics
(18)
Multidisciplinary Sciences
(15)
Patients
(14)
Mortality
(12)
Mutation
(12)
Respiratory System
(12)
Adult
(11)
Aged, 80 And Over
(11)
Quality Of Life
(11)
Biological And Medical Sciences
(10)
Hospitals
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Letter from Taiwan

Considering lead-time bias in evaluating the effectiveness of lung cancer screening with real-world data

Cost‐effectiveness of first‐line immunotherapies for advanced non‐small cell lung cancer

PM2.5 exposure and risk of lung adenocarcinoma in women of Taiwan: A case–control study with density sampling

Trend of Non-contrast Chest Computed Tomography Use in the Lung Cancer Screening Era: SEER-Medicare 2008–2016

The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasis

Estimation of disability free life expectancy in non small cell lung cancer based on real world data

The impact of driver mutation on the treatment outcome of early-stage lung cancer patients receiving neoadjuvant immunotherapy and chemotherapy

Estimating Taiwan's QALY league table for catastrophic illnesses: Providing real-world evidence to integrate prevention with treatment for resources allocation

Liquid biopsy genotyping in lung cancer: ready for clinical utility?

Economic Analysis of Tissue-First, Plasma-First, and Complementary NGS Approaches for Treatment-Naïve Metastatic Lung Adenocarcinoma

Lung cancer survival and mortality in Taiwan following the initial launch of targeted therapies: an interrupted time series study

Effects of removing reimbursement restrictions on targeted therapy accessibility for non-small cell lung cancer treatment in Taiwan: an interrupted time series study

Preventing and treating brain metastases with three first-line EGFR-tyrosine kinase inhibitors in patients with EGFR mutation-positive advanced non-small cell lung cancer

Cost-Effectiveness of Nivolumab Plus Ipilimumab With and Without Chemotherapy for Advanced Non-Small Cell Lung Cancer

Effect of BIM expression on the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs

QALYs and medical costs saved from prevention of a cancer: Analysis of nation-wide real-world data of Taiwan with lifetime horizon

Typical antipsychotics is associated with increased risk of severe exacerbation in asthma patients: a nationwide population-based cohort study

Downstream Complications and Healthcare Expenditure after Invasive Procedures for Lung Lesions in Taiwan

Estimating time and transportation costs associated with lung cancer screening and diagnostic lung procedures in Taiwan: a cross-sectional survey in a medical centre

Pembrolizumab and Chemotherapy Combination Prolonged Progression-Free Survival in Patients with NSCLC with High PD-L1 Expression and Low Neutrophil-to-Lymphocyte Ratio

Indigenous recurrent disseminated histoplasmosis in Taiwan

EGFR-TKI plus bevacizumab versus EGFR-TKI monotherapy for patients with EGFR mutation-positive advanced non-small cell lung cancer-A propensity score matching analysis

Multiple in-hospital counseling increases six-month smoking abstinence among individuals participating in a hospital-initiated smoking cessation program

Improved survival in patients with unresectable stage III EGFR‐mutant adenocarcinoma with upfront EGFR‐tyrosine kinase inhibitors

Suchergebnisse filtern